MedTrace Logo

HappyOrNot® Smileys and the Visual Analogue Scale (VAS) in the Assessment of Urinary Symptoms

NCT07269652 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-12-17

No results posted yet for this study

Summary

INTRODUCTION A simple and repeatable test would be valuable for assessing the severity and impact of urinary symptoms. Visual Analogue Scale (VAS) is a 10 cm line where a participant put a mark in place that describes best his satisfaction with woiding. VAS has been shown to correlate with flowmetry and International Prostate Symptom Score (IPSS). VAS is still a number and may not reflect participants satisfaction. HappyorNot smileys (HoN) (emoji faces) are used to measure customer satisfaction by pressing one of four emoji smilyes. Two of these are happy and two and unhappy.

OBJECTIVE:

\- To study the use of VAS and HoN in assessing urinary symptoms in men.

MATERIALS AND METHODS:

* 100 men referred to urology outpatient clinic in Tampere University Hospital or Seinäjoki Central Hospital due to urinary symptoms caused by benign Prostate Hyperplasia (BPH)
* Participants are asked to fill VAS and HoN and results are correlated with traditional symptom questionnaires and peak urinary flow and post-void residual volume.

Conditions

  • Prostate Hyperplasia

Interventions

DIAGNOSTIC_TEST

Visual analogue scale and HappyorNot smileys

VAS and HoN has not been studied before

Sponsors & Collaborators

  • Tampere University Hospital

    collaborator OTHER

  • Seinajoki Central Hospital

    lead OTHER

Principal Investigators

  • Mika Petri Raitanen, M.D., Ph.D., Associate Prof · Seinajoki Central Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2025-05-01
Completion
2025-05-01

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07269652 on ClinicalTrials.gov